largesse

 

Leonard Sank is a director of Oramed ORMP

Mr Sank acquired shares in Oramed over time by allotment, grant, and other means. Mr Sank is required to disclose his dealing in Oramed stock as an insider through the SEC Form 4

Mr Sank filed a Form 4 on 2 March 2021 disclosing that he had sold 453,125 of the 591,000 shares owned at a price of $3.68

The securities were transferred to Ledo Investment Holdings Trust that appears to reside in Tortola.  Mr Sank claims that the trust is managed by an independent trustee for the benefit of Mr Sank and his family.

The trades were claimed to have been executed on 26 February 2021 when Oramed stock price settled at $8.91 with 340,000 shares changing hands or $6.00 higher than Mr Sank's sale to his family trust.

Somewhere in Tortola or points beyond resides the $2.5 million largesse of Mr Sank as a seller.





Comments